Theradigm develops stem-cell-based therapies to treat diseases of the central nervous system. Building upon promising pre-clinical data, Theradigm is initially pursuing treatments for stroke and spinal cord injury. Other treatments under development will address traumatic brain injury. Theradigm's stem cells are used to provide trophic support, and potentially to rescue or replace injured tissue in the central nervous system
